6-Hydroxykaempferol 3,6-diglucoside ( —— )

产品货号. M31266 CAS No. 142674-16-6

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

6-Hydroxykaempferol 3,6-diglucoside
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

6-Hydroxykaempferol 3,6-di-O-glucoside and 6-hydroxykaempferol 3,6,7-tri-O-glucoside can inhibit platelet aggregation induced by collagen, they also show weak inhibitory effects on the adenosine 5'-diphosphate (ADP)- induced platelet aggregation.
产品描述

6-Hydroxykaempferol 3,6-di-O-glucoside and 6-hydroxykaempferol 3,6,7-tri-O-glucoside can inhibit platelet aggregation induced by collagen, they also show weak inhibitory effects on the adenosine 5'-diphosphate (ADP)- induced platelet aggregation.
体外实验

——
体内实验

——
同义词

——
通路

Others
靶点

Other Targets
受体

——
研究领域

——
适应症

——

计算器

产品手册

关联产品

Soraprazan

Soraprazan (BYK61359) 是选择性的钾通道竞争性的 H,K-ATPase (Ki=6.4 nM)的抑制剂，在胃腺的 IC50 为 0.19 μM。Soraprazan 与 H,K-ATPase 结合，Kd为 28.27 nM。Soraprazan 对酸分泌有直接抑制作用，对 H,K-ATPase 的选择性是 Na,K- 和 Ca- ATPases 的 2000 倍以上。
QS-21

QS-21, an immunostimulatory saponin, is a powerful vaccine adjuvant that stimulates both Th2 humoral and Th1 cell-mediated immune responses by interacting with antigen presenting cells (APCs) and T cells.
MIF098

MIF098 是一种巨噬细胞迁移抑制因子 (MIF) 拮抗剂，可抑制肺平滑肌细胞增殖、迁移和纤维化。MIF098 可用于免疫炎症相关疾病研究。